Response to “Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience” [Letter]

Abstract

Nastiti Intan Permata Sari, Sarwo Handayani Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Science Centre, Bogor, West Java, IndonesiaCorrespondence: Nastiti Intan Permata Sari, National Research and Innovation Agency (BRIN), Cibinong Science Centre, Jl. Raya Jakarta - Bogor Km. 46, Cibinong, Bogor, West Java, Indonesia, Email [email protected]

Keywords

• neurofibromatosis type 1
• epidemiology
• clinical features